Dimed S.A. Distribuidora de Medicamentos (BVMF:PNVL3)

BVMF:PNVL3 Revenue

Dimed S.A. Distribuidora de Medicamentos had revenue of 1.51B BRL in the quarter ending June 30, 2026, with 14.87% growth. This brings the company's total for the last twelve months to 5.90B, up 14.42% year-over-year. In the year 2025, Dimed S.A. Distribuidora de Medicamentos had annual revenue of 5.51B with 11.53% growth. That makes Dimed S.A. Distribuidora de Medicamentos the 7,202nd largest company in the world by revenue and 116th in Brazil.

• Revenue (ttm): 5.90B
• Revenue Growth: +14.42%
• P/S Ratio: 0.27
• Revenue / Employee: 516.23K
• Employees: 11,426
• Market Cap: 1.58B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Retail 4.73B 95.7%
• Wholesale 213.80M 4.3%

Fiscal year ended Dec 31, 2024 See the full BVMF:PNVL3 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	5.51B	569.66M	11.53%
Dec 31, 2024	4.94B	481.45M	10.79%
Dec 31, 2023	4.46B	470.54M	11.79%
Dec 31, 2022	3.99B	765.07M	23.72%
Dec 31, 2021	3.23B	406.30M	14.41%

Data Source: S&P Global Market Intelligence Last updated: Aug 6, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 24, 2026

Data Sources Report a data error